Abstract:<p>Chemotherapy‐induced peripheral neuropathy (CIPN) is among the most disabling and frustrating problems for cancer survivors. The neurotoxicity caused by cisplatin varies greatly among patients, and few predictors of appearance, duration of symptoms, susceptibility, or severity are available. A deeper understanding of the mechanisms underlying individual differences in status, severity, or sensitivity in response to cisplatin treatment is therefore required. By analyzing the GSE64174 gene expression profile and constructing a weighted gene co‐expression network analysis (WGCNA) network, we screened gene modules and hub genes related to CIPN status, severity and sensitivity. We first identified the transcriptome profile of mouse dorsal root ganglion (DRG) samples and transformed their genes to human DRG counterparts. We then constructed WGCNA gene modules via optimal soft‐threshold power‐identification and module‐preservation analysis. Comprehensive analysis and identification of module hub genes were performed via functional‐enrichment analysis and significant common hub genes were identified, including "Cytoscape_cytoHubba," "Cytoscape_MCODE," and "Metascape_MCODE." Brown, green, and blue modules were selected to represent CIPN sensitivity, status and severity, resepectively, via trait‐module correlational analysis. Additionally, functional enrichment analysis results indicated that these three modules were associated with some crucial biological functions, such as neutrophil migration, chemokine‐mediated signaling pathway, and PI3K‐Akt signaling pathway. We then identified seven common hub genes via three methods, including CXCL10, CCL21, CCR2, CXCR4, TLR4, NPY1R, and GALR2, related to CIPN status, severity and sensitivity. Our results provide possible targets and mechanism insights into the development and progress of CIPN, which can guide further transformation and pre‐clinical research.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the insufficient understanding of the mechanism of chemotherapy - induced peripheral neuropathy (CIPN), especially in the case of significant individual differences in patients' sensitivity, status, and severity to cisplatin treatment. Specifically, the paper aims to screen out gene modules and hub genes related to CIPN status, severity, and sensitivity by analyzing gene expression profiles and constructing weighted gene co - expression network analysis (WGCNA). This helps to reveal the potential mechanisms of CIPN development and provides new targets and mechanistic insights for preventing or managing CIPN symptoms. ### Main research methods 1. **Dataset**: Use the GSE64174 gene expression dataset from the Gene Expression Omnibus (GEO) database, which contains 47 L4 - L5 dorsal root ganglion (DRG) samples from untreated, solvent - treated, and cisplatin - treated adult female C57BL/6J and A/J mice, with treatment times of 1 week and 4 weeks respectively. 2. **Gene expression pre - processing**: Convert mouse DRG genes into homologous genes of human DRG genes. 3. **Gene network construction and module identification**: Use the WGCNA algorithm to construct a gene co - expression network, determine the appropriate soft - threshold power, and construct gene modules through hierarchical clustering analysis. 4. **Module - trait correlation analysis**: Calculate the correlation between module eigengene (ME) and external traits (such as status, severity, and sensitivity), and screen out modules related to CIPN. 5. **Functional enrichment analysis**: Perform gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis on the screened modules to reveal their biological functions. 6. **Protein - protein interaction network and hub gene identification**: Use the STRING database to construct a protein - protein interaction (PPI) network, and identify hub genes through the Cytoscape plugins cytoHubba and MCODE and the Metascape tool. ### Main findings - **Gene modules**: 10 different gene co - expression modules were screened out, among which the brown module is highly correlated with CIPN sensitivity, the green module is negatively correlated with CIPN status, and the blue module is highly correlated with CIPN severity. - **Hub genes**: In the brown module, 5 hub genes were identified, including CXCL10, CCL21, TLR4, NPY1R, and GALR2; in the green module, 2 hub genes were identified, including CCR2 and CXCR4; in the blue module, multiple hub genes were identified, but there are no completely overlapping genes. - **Biological functions**: These hub genes are mainly involved in biological processes such as immune cell chemotaxis, inflammatory response, cell migration, and cell adhesion, especially CXCL10, CCL21, CCR2, CXCR4, and TLR4 may play important roles in the development of CIPN. ### Conclusion Through WGCNA analysis, the paper successfully screened out gene modules and hub genes related to CIPN status, severity, and sensitivity, providing a new perspective for the mechanism research of CIPN. These findings not only help to understand the pathogenesis of CIPN, but also provide potential targets for the development of new prevention and treatment methods.

Co‐expression gene modules involved in cisplatin‐induced peripheral neuropathy according to sensitivity, status, and severity